Skip to main content
Fig. 6 | Breast Cancer Research

Fig. 6

From: CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy

Fig. 6

IGF1R-KD significantly reduced the metastatic capacity of CD24+ cells. a Experimental strategy scheme is presented. b Representation of lung metastasis following 4 weeks of 10,000 cells inoculation into the tail vein of the WT mice. c Average of macrometastasis per lung in each group is displayed in the bar graph. Mann-Whitney test performed to compare the difference between the groups. **P < 0.005. IGF1R insulin-like growth factor receptor, KD knockdown

Back to article page
\